老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Epizyme Inc.

1.47
0.0000
成交量：- -
成交额：3,275.66万
市值：2.47亿
市盈率：-0.91
高：1.47
开：1.47
低：1.47
收：1.47
52周最高：5.80
52周最低：0.4110
股本：1.68亿
流通股本：1.36亿
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-1.6121
每股收益(LYR):-2.4465
净资产收益率：-877.48%
总资产收益率：-39.25%
市净率：-12.20
市盈率(LYR):-0.60

数据加载中...

总览公司新闻公告
2021/02/23

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/23

重要事件披露

8-K - Current report
2020/11/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/06

重要事件披露

8-K - Current report
2020/10/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/04

重要事件披露

8-K - Current report
2020/06/03

重要事件披露

8-K - Current report
2020/05/04

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/04

重要事件披露

Current report, items 2.02 and 9.01
2020/04/03

重要事件披露

8-K - Current report
2020/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/24

重要事件披露

Current report, items 2.02 and 9.01
2020/02/21

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
更多